Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05512390 |
|---|---|
| Brief Title: | A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL) |
| First Submitted : | August 22, 2022 |
| First Submitted that Met QC Criteria : | August 22, 2022 |
| First Posted : | August 23, 2022 |
| Last Update Submitted that Met QC Criteria : | March 4, 2024 |
| Last Update Posted : | March 5, 2024 |